Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Anemia × iron isomaltoside 1000 × Clear all

Phase

Status

Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 2 Non-hematological Malignancies 1 Anemia, Iron-Deficiency 1 Anemia 1

Interventions

Epoetin Alfa 43 Darbepoetin alfa 33 epoetin beta 10 ferric carboxymaltose 6 Cyclosporine 4 Cisplatin 4 ferrous sulfate 3 Radiotherapy 3 Lenalidomide 3 peginesatide 2 luspatercept 2 hematide 2 fludarabine 2 ferric gluconate 2 continuous erythropoietin receptor activator 2 Therapeutics 2 Filgrastim 2 Erythropoietin 2 Dexamethasone 2 Cyclophosphamide 2 Brachytherapy 2 Antilymphocyte Serum 2 ACE-011 2 thymoglobulin 1 ruxolitinib 1 roxadustat 1 reolysin 1 pegfilgrastim 1 obinutuzumab 1 leridistim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01280240 2013-06-04

PK-CIA-06

Pharmacosmos A/S

Phase 1 Completed

Classical hematology

Anemia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡